Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Haematologica|June 5, 2014
Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutationsHajnalka Andrikovics, Tunde Krahling, Katalin Balassa, et al.
Histopathology|March 31, 2012
Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteriaIrith Baumann, Monika Führer, Sonja Behrendt, et al.
Journal of Neuro-Oncology|October 3, 2009
Central nervous system involvement in CD4+/CD56+ hematodermic neoplasm: a report of two casesNóra Eros, Márta Marschalkó, Katalin Balassa, et al.
Orvosi Hetilap|October 19, 2018
[Change in paradigm in the treatment of pediatric acquired bone marrow failure syndromes in Hungary]Krisztián Kállay, Judit Csomor, Emma Ádám, et al.
European Journal of Human Genetics : EJHG|May 18, 2017
Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigreeKiran Tawana, Jun Wang, Péter A Király, et al.
British Journal of Haematology|October 20, 2012
Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosisEszter Rausz, Agnes Szilágyi, Boguslaw Nedoszytko, et al.
Pathology|January 5, 2019
Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasmsRéka Mózes, Ambrus Gángó, Adrienn Sulák, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 9, 2024
Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center LymphomaBence Bátai, Laura Kiss, Luca Varga, et al.
Haematologica|July 28, 2011
The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemiaSarolta Nahajevszky, Hajnalka Andrikovics, Arpad Batai, et al.
Leukemia & Lymphoma|October 9, 2012
Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemiaMagdalena Koszarska, Andras Bors, Angela Feczko, et al.
Pageof 7